文献速递神经免疫

预测抗NMDAR脑炎患者1年功能状态的评分

A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis.
PubMed 文献 · Neurology · 2018-12-21

多变量分析确定ICU入住、治疗延迟>4周、4周内无临床改善、MRI异常和CSF白细胞>20个/μL为独立预测因素。NEOS评分与1年不良功能状态概率强烈相关(0或1分3%至4或5分69%,p<0.001)。

要点

  • NEOS评分包含5个变量,每项1分,总分5分。
  • 评分越高,1年不良功能状态(mRS≥3)概率越高。
  • 可用于估计临床病程并识别可能受益于新疗法的患者。

核心结论

  • NEOS评分能准确预测抗NMDAR脑炎患者1年功能状态。

研究设计与样本

  • 通过单变量分析识别与不良状态相关的因素,并纳入多变量 logistic 回归模型构建5分制预测评分。

主要发现

  • 单变量分析显示ICU入住(p<0.001)、治疗延迟>4周(p=0.012)、4周内无临床改善(p<0.001)、运动障碍(p=0.001)、中枢性低通气(p<0.001)、CSF白细胞升高(p<0.001)、CSF蛋白升高(p=0.027)和MRI异常(p=0.002)与1年功能状态相关。
  • 多变量回归确定ICU入住、治疗延迟>4周、4周内无临床改善、MRI异常和CSF白细胞>20个/μL为独立预测因素。
  • NEOS评分与1年不良功能状态概率强烈相关:0或1分对应3%,4或5分对应69%(p<0.001)。

关键数值与推荐

  • NEOS评分共5分,每个独立预测因素赋值1分。
  • 不良功能状态定义为改良Rankin量表评分≥3。
  • 1年不良功能状态概率:NEOS评分0或1分为3%,4或5分为69%(p<0.001)。

临床怎么用

  • NEOS评分可用于估计抗NMDAR脑炎患者诊断后的临床病程。
  • 评分可能有助于识别可能受益于新疗法的患者。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To construct a grading score that predicts neurologic function 1 year after diagnosis of anti-NMDA receptor (NMDAR) encephalitis. METHODS: Three hundred eighty-two patients with detailed information and functional status at 1 year were studied. Factors associated with poor status (defined as modified Rankin Scale score ≥3) were identified and incorporated into a multivariate logistic regression model. This model was used to develop a 5-point prediction score, termed the anti-NMDAR Encephalitis One-Year Functional Status (NEOS) score. RESULTS: Intensive care unit admission (p < 0.001), treatment delay >4 weeks (p = 0.012), lack of clinical improvement within 4 weeks (p < 0.001), movement disorder (p = 0.001), central hypoventilation (p < 0.001), elevated CSF white blood cell count (p < 0.001), elevated CSF protein level (p = 0.027), and abnormal MRI (p = 0.002) were associated with 1-year functional status in univariate analysis. Intensive care unit admission, treatment delay >4 weeks, lack of clinical improvement within 4 weeks, abnormal MRI, and CSF white blood cell count >20 cells/μL were independent predictors for outcome in multivariate regression modeling. These 5 variables were assigned 1 point each to create the NEOS score. NEOS score strongly associated with the probability of poor functional status at 1 year (3% for 0 or 1 point to 69% for 4 or 5 points, p < 0.001). CONCLUSIONS: The NEOS score accurately predicts 1-year functional status in patients with anti-NMDAR encephalitis. This score could help estimate the clinical course following diagnosis and may aid in identifying patients who could benefit from novel therapies.

来源:Neurology,查看原文。版权归原作者所有。

引用

  1. Balu R, McCracken L, Lancaster E, et al. A score that predicts 1-year functional status in patients with anti-NMDA receptor encephalitis. Neurology. 2018. PMID: 30578370. doi:10.1212/WNL.0000000000006783

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。